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1. INTRODUCTION 
 
1.1 Exosome overview 
Exosomes are bi-lipid membrane vesicles that belong to the extracellular vesicles (EV) class, 
together with microvesicles and apoptotic bodies. Among these, exosomes are the only ones 
with endocytic origin and homogeneous shape and size (40-100nm). Their biogenesis starts 
from the inward budding of the membranes of late endosomes, also called multi-vesicular bodies 
(MVB), resulting in the formation of intraluminal vesicles (ILVs) 1. During ILVs formation, 
transmembrane proteins are incorporated into the folding membrane while the cytosolic 
components are engulfed within the vesicles. The MVBs move up to the cell surface, fuse with 
the plasma membrane and, finally, release ILVs outside the cell. Exosomes are released in vitro 
by several cell types, and have been isolated in vivo from a variety of body fluids (such as urine, 
saliva and plasma). Even if their protein composition varies depending on the cell type of origin, 
a conserved set of membrane markers has been identified, such as Tetraspanins (CD63, CD81 
and CD9). Molecules like Alix, TSG101 (Tumor susceptibility gene 101) and clathrin are highly 
associated with exosomes. One class of cytosolic proteins, the largest small GTPase family, the 
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Rabs, interact with proteins involved in vesicular transport and fusion, regulating exosome 
docking and membrane fusion, supported by the Annexins’ family. Concerning their content, 
exosomes are enriched with a wide variety of proteins, such as: heat-shock proteins, metabolic 
enzymes, ribosomal proteins, signal transduction proteins, adhesion molecules, ATPases, 
cytoskeletal proteins and ubiquitin molecules 2. Exosomes content is also enriched with specific 
nucleic acids, in particular RNAs and miRNAs, which exist within protein complexes. 
Exosomes have been originally attributed the function of protein excess removal. They are 
attracting increasing scientific interest, though, since they are no longer considered as simple 
containers for cell waste, but as cellular structures involved in cell-cell communication. Once in 
the extracellular space, they are able to interact with target cells inducing, according to the 
delivered molecules, a modulation of the phenotype towards a differentiated or activated state. 
They have been extensively studied in cancer research and immunology, because they can affect 
cancer stem cell niches and tumour progression 3, mediate antigen presentation, responses to 
infections and autoimmunity. These features suggested novel approaches involving them as 
biomarkers or immunotherapeutic agents 4, 5. More recently, exosomes have entered the scenario 
 6 
 
of the neurodegenerative disorders 6 and cardiovascular diseases 7 pathophysiology, potentially 
playing both diagnostic and therapeutic roles.  
 
1.2 Exosomes and stem cells: the paradigm of cardiovascular regenerative medicine. 
The fields of stem cells and regenerative medicine are paying increasing attention to the effects 
mediated by exosomes, particularly in the cardiovascular system. In fact, exosomes derived 
from mesenchymal, cardiac and embryonic stem cells 8-16 have been shown to exert angiogenic 
and cardioprotective effects in ischaemic heart failure models, mediating survival and cell-cycle 
re-entry of cardiomyocytes as well as activation of endogenous cardiac repair by resident 
progenitor cells. Mesenchymal stem cell-derived exosomes have been shown to produce 
vascular remodelling and tissue protective effects in a stroke model, as well 17. Such strong 
paracrine regenerative approach may overcome several hurdles occurring in the clinical 
translation of heterotopic stem cell therapy protocols, such as those related to immunologic (i.e. 
allogeneic mesenchymal cell therapy) or oncologic (i.e. embryonic stem cell-derived teratomas) 
concerns, since such approach would include only a non-cellular regenerative product, that is 
EVs. Concerning autologous orthotopic cell products for cell therapies, such as resident Cardiac 
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Progenitor Cells (CPCs) 18-20 where cardiovascular commitment is intrinsic, paracrine effects 
are nonetheless important co-factors in the overall therapeutic outcome, together with direct 
regeneration. In fact, cell sources are needed with unequivocal cardiomyogenic commitment to 
achieve successful regeneration, and resident CPCs, which have been tested in many animal 
models and recently in clinical settings, seem to have a very promising potential 21, 22.  Initially, 
the idea was that transplanted cells, once injected in the infarcted tissue, could directly 
regenerate new cardiomyocytes. However, pre-clinical studies in different animal models have 
shown that many of the transplanted cells are lost within few hours after injection, so that only 
about 5-10% of them can be detected after 1 day 23, 24. Furthermore, a large number of cells, 
although initially retained, die because of the unsuitable microenvironment of the damaged 
tissue. Moreover, the cells that still survive in the heart, only partially differentiate into new 
cardiomyocytes or vessels 25-27. However based on the evidence that cell injection has a positive 
outcome on heart function, even without significant long-term cell engraftment, and that even 
concentrated stem cell-conditioned media could sustain regenerative effects 28, a new idea has 
been formulated: the paracrine hypothesis. The rationale of this idea is based on the increasing 
evidence showing that the observed therapeutic effects, even with cardiovascular-committed 
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resident CPCs, are partly, but significantly, mediated by secretion of humoral factors 26, 29. For 
example, it has been shown that mesenchymal stem cell-conditioned medium (MSC-CM) 
enhances cardiomyocytes survival after hypoxia induced injury, promotes angiogenesis and 
reduces infarct size 30, 31. Paracrine effects have been shown to be responsible also for 
intercellular communications among different stem cell types, mediating for example the 
enhancement of cardiovascular commitment of MSCs by CPCs 32. Moreover a study from 
Arslan et al. 10, demonstrated that exosomes isolated from MSC-CM are able to increase ATP 
levels, decrease oxidative stress, activate survival pathways, reduce infarct size and prevent 
adverse remodelling after myocardial ischemic injury (figure 1). These evidences allowed 
exosomes to enter, for the first time, the scenario of paracrine mechanisms of cardiac 
regeneration. Thereafter several studies have demonstrated that exosomes, independently from 
the cell type of origin, exert an in vitro pro-survival action in hypoxia conditions (as a post HF 
damage simulation), protect from oxidative stress, promote proliferation, migration and 
formation of tubes in HUVEC 10-16, 33, 34. It has also been demonstrated that cardiomyocyte 
progenitor cell (CMPC)-derived exosomes are able to stimulate endothelial cells migration in 
vitro, increasing capillary density, through mechanisms involving matrix metalloproteinases 
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(MMP) and extracellular MMP inducers 35 (figure 1). CPCs themselves release a wide panel of 
humoral factors or vesicles (growth factors, cytokines, chemokines, regulatory binding 
proteins), defining a specific functional “secretome”, which exerts proangiogenic and anti-
apoptotic effects 26, 36, and mediates the activation of endogenous repair mechanisms in vivo 27. 
Furthermore, it has been demonstrated that CPCs are able to release exosomes 37, whose 
regenerative effect has been investigated in two recent papers 13, 38. The results evidenced that 
CPC-derived exosomes are able to stimulate angiogenesis in vitro, promote cardiomyocytes 
proliferation and inhibit apoptosis. Similar beneficial outcomes have been observed in vivo 
using a myocardial infarction (MI) mouse model with injection of CPCs conditioned medium 
(CPCs-CM). In fact, the direct injection of the injured tissue with the exosomes fraction isolated 
from CPCs-CM, inhibited cardiomyocyte programmed cell death, enhanced angiogenesis, and 
improved hearth functionality. These effects were similar to what observed with CPCs 
transplantation in the CADUCEUS clinical trial 21. Through a qualitative analysis of the CPCs 
secreted exosomes content, these studies identified several microRNAs (miRs) as new and 
important mediators of the beneficial effects of regenerative therapy approaches. In general, 
miR-210 and miR-132 inhibit apoptosis in cardiomyocytes and enhance tube formation in 
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endothelial cells, respectively, by the ephrin A3, PTP1b and RasGAP-p120 down-regulation 13. 
Furthermore miR-146a, in synergy with miR-22 and miR-24, interfering with Toll-like receptor 
and pro-fibrotic TGF-beta signalling pathways, modulates cardiac fibrosis decreasing scar 
formation and increasing, at the same time, the viable tissue portion 38.  
Overall, these results underline the hypothesis of considering CPC-derived exosomes as a 
potential therapeutic agents or, at least, as important mediators of regenerative mechanisms for 
cardiac cell therapy (figure 1).  
   
 1.3 Exosomes: targets or contaminants.  
EVs are present in the mammalian plasma, which means that standard Foetal Bovine Serum 
(FBS), used as cell culture supplement, contains abundant exogenous EVs. Thus, exosome-free 
media recipes are necessarily required for the in vitro collection of cell-type specific exosomes 
released in the supernatant, for both their isolation and use as therapeutic tools, as well as for 
characterization purposes. Nevertheless, bovine exosomes represent an active biological 
component of FBS, contributing to the overall trophic and proliferative stimuli it grants to cell 
culture media. A major emerging issue, in any exosome-related research field, is the conflict 
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between the desired cell-specific purity of any exosome isolation protocol, and the not negligible 
technical requirements for efficient FBS biological activity on cell cultures. Two recent papers 
39, 40 have underlined how the effects of bovine exosomes on cell culture yields and outcomes 
are important factors to take into account. It has been demonstrated that, the main effect of 
bovine exosome-depleted media is indeed a reduction of cell growth and proliferation rate. This 
aspect could highlight the need to analyse, in a critical way, the in vitro results obtained until 
today, in order to understand if and how much the exosomes present in serum might have 
influenced them. Furthermore, it has been shown that exosomes yield, characteristics and 
subsequently their effects on cell cultures, are influenced by the isolation protocol used. For this 
reason, it is important to choose an exosome isolation method according to the requirements 
needed for downstream applications.  
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Figure 1. Exosomes derived from MSCs, MPCs and CPCs therapeutical effects based on      
                 references (10,13,35,38). 
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1.4 Exosome isolation protocols 
In the last decade, the role of exosomes as one of the key factor for tissue regeneration has 
emerged, considering the tremendous impetus given to their biotechnological and clinical 
translation. Therefore, for reliable research data collection, underlying any possible future 
clinical perspective, many isolation methods will have to be developed to reach a high degree 
of exosome recovery and specificity, to reduce procedure time and to use easily accessible 
equipment (Table 1). Up to date, every method presents pros and cons that, in different ways, 
block a possible scalability for a future clinical translation. Starting from the significant effects 
of FBS exosome-depletion from cell culture media, it could be important, at least in some cell 
culture protocols, to consider the best suitable isolation method while planning a 
characterization of cell specific exosomes, and to verify how much the depletion of bovine 
exosomes from FBS could modify the specific cell phenotype under investigation. The acquired 
experience may therefore improve the results quality and reliability, making them real facts and 
not artefacts. 
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1.4.1 Ultracentrifugation  
The most commonly used protocol for exosome purification involves several centrifugation and 
ultracentrifugation (UC) steps 41. Briefly, the first three steps are designed to eliminate cells (300 
rcf for 10 minutes), large dead cells (2,000 rcf at 4°C for 10 minutes) and large cell debris 
(10,000 rcf at 4°C for 30 minutes). After each step, pellets are discarded and the supernatant is 
kept for the next. At the end, the supernatant is ultracentrifugated two times at 100,000 rcf at 
4°C for 70 minutes to pellet exosomes and discard contaminating proteins. Starting from this 
protocol, in 2014 Cvjetkovic et al. 42 analysed if different rotors, such as fixed angle (FA) or 
swinging bucket (SW) rotors, and variation in length of ultracentrifugation were able to affect 
exosomes yield and purity. Both rotor types could be used to isolate vesicles with similar 
characteristics, in terms of exosomal features, but the composition of the pellet generated by 
each rotor is slightly different. In particular, the ratio between the protein and RNA fraction 
within the pellet is higher in the SW than the FA rotor. These results suggest that the choice of 
the rotor has an impact on the quality of the isolated material and, as the authors suggest, it 
would be advisable and important to report in any protocol the relative centrifugal force (RCF) 
as well as the k-factor, to ensure accurate replication of any exosomal isolation procedure. 
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Concerning the centrifugation time, they demonstrated that by extending it, a higher vesicle 
yield could be obtained. Therefore, the common 70 minutes ultracentrifugation protocol would 
not be sufficient for the isolation of exosomes, but, on the other side, prolonged time is to be 
avoided to reduce soluble proteins contamination. The authors then suggest a 4 hours 
centrifugation time, underlying that longer centrifugation programs could be good for exosome 
isolation only when followed by purification steps. For that reason, in most of the cases, the 
exosome pellet, including contaminants, normally undergoes further centrifugation procedures, 
such as gradient of sucrose or sucrose cushions to separate vesicles and particles based on their 
density. However, as Jeppesen et al. 43 suggest, the use of cushions and gradients increases the 
time required for purification, and results in loss of sample material. Furthermore, it is also still 
unclear if the floatation in gradients may affect the biological and functional characteristics of 
exosomes. The authors examined the impact of differential ultracentrifugation g-forces (ranging 
from 33,000 to 200,000 rcf) on the exosome isolation outcome from two different cell types. A 
higher purity of the samples was found in both cell lines after different ultracentrifugation rates. 
Furthermore, rising centrifugal g-force leads to increased quantity of contaminating proteins in 
pellets, while there is a tendency to reach plateau for the number of exosomes recovered. Based 
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on their results, it seemed that contamination from mitochondria and ER (microsome) could 
efficiently be eliminated by pre-clearing centrifugation steps at 2,000 rcf and 33,000 rcf, 
respectively, even if these additional steps reduced the final yield of the isolation process. They 
also observed, especially in the higher g-force fractions, different expression patterns for two 
exosomal markers (TSG101 and syntenin). Their conclusion was that, probably, there were 
some sub-populations of exosomes expressing different markers and with different 
sedimentation profiles. 
 
1.4.2 Commercial exosome precipitation solutions 
In the last years, several polymer-based exosome isolation kits have become commercially 
available. Concerning the most used in the literature, the Exo-Quick TC from System-Bio is 
useful for a quantitative isolation of exosomes from low sample volumes, it is compatible with 
any bio-fluid, and is an effective and proven alternative to ultracentrifugation. According to the 
literature and the instruction manual, the culture medium is centrifuged at 3,000 rcf for 15 
minutes and the supernatant sieved through 0.22 um filtering units. The appropriate volume of 
precipitation solution (according to the manufacture’s suggestions) is added to the medium, 
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mixed by inverting and placed at 4°C, ranging from 30 minutes to overnight for serum and other 
bio-fluids, or culture media, respectively. After refrigeration, the mixture is centrifuged at 1,500 
rcf for 30 minutes to remove all traces of fluids, and the exosome pellet is ready to be used. With 
these solutions, high quality exosomes can be quickly and easily isolated from most biofluids, 
using a protocol that can be easily performed on multiple samples and requires very low volumes 
of input. Furthermore, isolated exosomes retain biological activity and can be used in functional 
assays. 
 
1.4.3 Heparin affinity purification 
In 2015 Balaj et al. 44 have shown that a three day heparin-based affinity chromatography 
protocol can be used to purify intact EVs to study their functional activities, or to simply use 
them as isolated biomarkers from bio-fluids.  Briefly, the 24-hour conditioned media (DMEM 
with 5% overnight-UC EV-depleted FBS) was first centrifuged at 300 rcf for 10 minutes to 
remove cells, then the supernatant was centrifuged at 2,000 rcf for 15 minutes to remove other 
debris, and finally filtered. At this point, media was concentrated by centrifuging at 1,000 rcf 
for 10 minutes using a 100 kDa Molecular Weight Cutoff (MWCO) ultra-filtration device. For 
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heparin purification, the concentrated conditioned media was added to heparin coated beads, 
incubated overnight on a tube rotator at +4°C to allow binding of EVs to the beads. Heparin 
beads were spun at 500 rcf for 5 minutes and the unbound fraction (supernatant) was collected.  
Heparin-coated beads were washed several times with PBS, each wash supernatant was saved, 
and a solution of NaCl in PBS was added to the beads and incubated overnight at +4°C on a 
tube rotator. Finally, heparin-coated beads were centrifuged at 500 rcf for 5 minutes, and the 
supernatant, corresponding to the eluate, was collected and stored at −80°C. In the same work, 
they also compared, in terms of yield and scalability, the chromatography protocol with 
ultracentrifugation and commercial kit. They found that, even if starting from the same input 
volume of media, the yield of RNA was similar in all methods, and the affinity purification is a 
more scalable method than centrifugation-based purification. 
 
1.4.4 Sequential filtration 
As discussed in section 3.1 UC protocols are incompatible with future high-throughput 
automation of exosome isolation and characterization processes, and the development of 
clinically implementable diagnostics or therapies. Starting from these considerations, in 2014 
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Heinemann et al. 45 proposed sequential filtration as a simplified, clinically applicable method 
for robust and specific exosomes isolation from biofluids. Their protocol derived from a 
previous method proposed by Lamparski et al. 46, based on tangential flow filtration (TFF) and 
ultracentrifugation on a deuterium-sucrose cushion, but in their case, they tried to avoid the 
second part. Sequential filtration consists of three steps: 1) Dead-End filtration, 2) Tangential 
Flow filtration, and 3) Track-etch filtration. In the first part, the 48-hour conditioned media (with 
0.2% of TFF exosome-depleted FBS) was filtered at 22°C using a 0.1 um membrane to eliminate 
large and rigid media components. In the second step, the filtrate was continuously aspirated 
from a conical bottle, pumped through a fiber system, with a very low trans-membrane pressure 
(1.5 and 2.5 PSI), and recycled into the conical bottle. With this mechanism, large molecules, 
such as free proteins, were discarded. The filtrate went through five rounds of dia-filtration to 
deplete the sample from contaminants smaller than 500-kDa. Finally, the sample was loaded 
into a syringe pump and attached to a disposable pressure transducer with a 100 nm filter. The 
filtration took place at 22°C with a pressure below 3.5 PSI. Compared to a sequential 
ultracentrifugation pellet, in which they obtained 11% more particles, sequential filtration 
yielded a more exosome-enriched sample with >80% of the particles in the exosomes size range. 
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1.4.5 Size-exclusion chromatography  
Size-exclusion chromatography (SEC) is commonly used to isolate platelets from platelet-rich 
plasma, and recently Böing et al. 47 have investigated the efficacy of single-step SEC for 
isolation of extracellular vesicles from human platelet-free supernatant. Platelets were isolated 
with 3 cycles of centrifugation for 20 minutes at 1,550 rcf and 20°C. According to the authors, 
SEC has several major advantages compared to the most used protocols for vesicles isolation, 
such as UC. For example, there is no risk of protein complex formation and vesicle aggregation, 
and the high viscosity of plasma does not affect the recovery of vesicles. The chromatographic 
column consists of Sepharose CL-2B in a 10mL plastic syringe with a diameter of 1.6 cm and 
height of 6.2 cm. The supernatant was loaded on the column, followed by elution with PBS/ 
0.32% citrate (pH 7.4).  Briefly, they showed that vesicles of a diameter larger than 75nm can 
be isolated from complex body fluids, such as plasma, by single-step SEC. Compared to 
ultracentrifugation, SEC results in a good recovery of vesicles (43% vs 2-80%) with almost 
complete removal of contaminants, taking less than 20 minutes (much less time, if compared to 
2-96 hours for ultracentrifugation). Thus, in general, isolation of vesicles by SEC is quick, easy 
and cheap. However, for Welton et al. 48 “homemade” columns create problems related to 
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reproducibility, such as variations from column to column, and the time needed to allow 
columns to settle without the formation of bubbles. In this perspective, they analysed the 
potential utility of a commercially available size-exclusion chromatography column for rapid 
purification of vesicle, exhibiting exosome characteristics. Seven days CM (10% 18-hour UC 
exosome-depleted FBS) was centrifuged (400 rcf for 10 min and 2000 rcf for 15 min) and 
filtered through a 0.22 um membrane to remove cell debris. Conditioned medium was added to 
the commercial column prior to elution with EDTA-PBS buffer. However, even if serial 
fractions revealed a peak for typical exosomal proteins (such as CD9, CD81), and the columns 
showed good reproducibility with the exosome-relevant material being collected in less than 10 
minutes, nonetheless the post-column vesicle concentration steps lead to low nanoparticles 
recovery (a loss of over 94%). In conclusion, even if this commercially available column 
provides a convenient, reproducible and highly effective means of eliminating approximately 
95% of non-vesicular proteins from biological fluid samples, several optimizations are certainly 
still required to minimize vesicle loss. 
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Table 1. Comparison of different exosome isolation methods based on analysed papers (41-48) 
 
  
Time 
 
Exosome recovery 
Exosome 
specificity 
 
Scalability 
 
Pros and cons 
 
 
Ultracentrifugation(41,42,43) 
 
 
 
 
2-96h 
 
 
2-80% 
 
 
YES/NO 
 
NOT YET 
(too much 
variability ) 
 
Standard gold method but very high 
variability depending on physical 
parameters and equipments. 
 
 
Commercial exosome 
precipitation kit(44) 
 
 
 
2-20h 
 
 
~80% 
 
 
YES 
 
 
YES 
 
Easily accessible, does not require 
expensive equipments or protocol 
optimization. 
 
 
Heparin affinity 
purification(44) 
 
 
 
~33h 
 
 
~80% 
 
 
YES 
 
 
YES 
 
More scalable than ultracentrifugation 
but requires multiple steps based on 
different methods. 
 
 
 
Sequential filtration(45,46) 
 
 
Dependent on 
filtering rate 
 
 
>80% 
 
 
YES 
 
 
YES 
 
Highest exosomes recovery but 
requires accurate monitoring of flux 
and pressure parameters 
. 
 
 
SEC(47,48) 
 
 
 
~10’-20’ 
 
43% (without the 
concentration step) 
 
 
NO 
 
YES/NO 
(depending on 
the column) 
 
 
 
Still needs accurate optimization for 
contaminants removal. 
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2. AIM OF THE THESIS 
 
Myocardial infarction is still the leading cause for mortality in the Western World. Up to date, 
the only conclusive therapeutic strategy is heart transplantation that is limited by organs 
availability and immunological issues. In the last decade, research has focused its attention on 
cardiac cell therapy as a potential alternative tool to repair a damaged heart and restore, at least 
partially, its function after injury. Resident CPCs have been tested in multiple animal models, 
and in few clinical trials, and they seem to hold a very promising potential 20-22. However, it has 
been demonstrated that many of the injected cells are lost within few hours after injection, so 
that only about 5-10% of them can be detected after 1 day 23. Moreover, the minority of cells 
that survive in the unsuitable ischemic microenvironment of the damaged heart tissue have not 
been shown to directly differentiate into new cardiomyocytes with high efficiency 25, 49.  
However, based on the evidence that cell injection has a positive outcome on heart function even 
without long-term engraftment, it has been suggested a paracrine hypothesis. The rationale of 
this idea is based on the increasing evidence showing that the observed therapeutic effects, even 
with cardiovascular-committed resident CPCs, are significantly mediated by stem cell secretion 
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of humoral factors 26, 29. CPCs release a wide panel of humoral factors and vesicles defining a 
specific functional “secretome”, which exerts proangiogenic, anti-apoptotic and commitment 
effects 26, 32, 36, 38, 50, and which mediates in vivo the activation of endogenous repair mechanisms 
27. Furthermore, recently it has been shown that CPCs secrete exosomes with proliferative, 
angiogenic and anti-apoptotic properties both in vitro and in vivo 13, 37, 38. These evidences 
support the idea that these vesicles mediate positive paracrine functional effects crucial for 
cardio-protection. Currently, based on their potential, the principal scientific interest is the 
characterization of exosomes content, derived from different cell types. However, only few 
studies have analysed the possible in vitro effects of bovine serum-derived exosomes on cell 
proliferation or differentiation 39, 40. Our group has recently demonstrated how CPC culture is 
largely influenced by serum origin and preparation 51, and it has been shown how different media 
ingredients, signalling molecules and the pathways they activate can significantly affect CPC 
biology 52-54. In addition, it is well known that a large amount of exosomes is normally present 
in FBS. Based on these evidences, the aim of this study was to analyse the in vitro effects of 
exosome-depleted FBS on the proliferation and differentiation properties of CPCs, as an 
important tool to optimize and scale up CPC production in vitro.  
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3. MATERIAL AND METHODS 
 
3.1 Cell cultures 
After informed consent, under an Institutional Review Board approved protocol, surgical 
auricola biopsies were collected from different patients. Biopsies were cultured as explants, and 
CPCs were isolated with the Cardiospheres (CSps) protocol, as previously described 55, 56. 
Briefly, isolated myocardial tissue was cut into 1- to 2-mm3 pieces, washed with Ca2+-Mg2+–
free phosphate-buffered solution (PBS) (Invitrogen), and digested at 37°C with 0,2% trypsin 
(Invitrogen) for 15 minutes. Tissue fragments were washed with complete explant medium 
(CEM) (Iscove’s Modified Dulbecco’s Medium [IMDM] supplemented with 20% FBS (Gibco), 
100 U/mL penicillin G, 100 µg/mL streptomycin, 2 mmol/L L-glutamine, and 0,1 mmol/L 2-
mercaptoethanol) and were cultured as explants in CEM at 37°C in normoxic conditions (5% 
CO2 and 21%O2), on Fibronectin coated plates (BD Biosciences). After 3 weeks of culture, 
Explant derived cells (EDCs) were collected by pooling two washes with Ca2+-Mg2+– free PBS, 
one wash with 0,53 mmol/L EDTA (Versene, Invitrogen), and one wash with 0,2% trypsin and 
0,53 mmol/L EDTA (Invitrogen) at room temperature under visual control. The cells obtained 
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were seeded at 0,4x105cells/mL in poly-D-lysine-coated 12-multiwell plates (BD Bioscences) 
in CSps medium (CSM) (35% complete IMDM supplemented with 10% FBS [CSM NORM] or 
10% ultracentrifuged FBS (Gibco) [CSM UCF] or 10% exosome-depleted FBS (System-Bio) 
[CSM DEPL], 65% DMEM–Ham F-12 mix containing 2% B27, 0,1 mmol/L 2-
mercaptoethanol, 10 ng/mL epidermal growth factor [EGF], 20 ng/mL basic fibroblast growth 
factor [bFGF], 40 nmol/L cardiotrophin-1 (all Peprotech), 40 nmol/L thrombin (Sigma), 
antibiotics and L-Glutamine, as in CEM). After 5 days of culture, CSps from the three different 
culture conditions were formed and collected. The EDCs that were not used to obtain CSps were 
collected and grown on a Fibronectin-coated 6-multiwell plates, 0,1x105 cells/well, in presence 
of IMDM supplemented with 20% FBS [IMDM NORM] or 20% ultracentrifuged FBS [IMDM 
UCF] or 20% exosome-depleted FBS [IMDM DEPL], for 10 days. 
 
3.2 Exosome depleted FBS 
FBS, purchased from Gibco, was filtered (0,2 µm) before adding to the NORM media. To obtain 
the UCF media, the same serum from Gibco, was ultracentrifuged for 18 hours at 165000 rcf 
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(SW 41 Ti rotor, Beckman Coulter). The exosome-depleted FBS was purchased directly from 
System-Bio and filtered (0,2 µm) before adding to the DEPL media. 
 
3.3 ELISA assay 
The three different FBS (NORM, DEPL and UCF) underwent an ELISA assay (System 
Biosciences) to measure their exosomes content (number per mL of serum). Exosomes 
precipitation was performed using ExoQuick precipitation solution (System Biosciences) that 
allows pelletting exosomes directly with a simple centrifugation protocol. Once obtained the 
exosomes from each serum, the ELISA protocol was perfomed following the manufacturer’s 
instructions, using a specific primary antibody against the exosomes membrane protein CD63, 
and a horseradish peroxidase enzyme-linked secondary antibody (goat anti-rabbit). After the 
addition of a Super-sensitive TMB ELISA substrate and a Stop Buffer to provide a fixed 
endpoint, the spectrophotometric lecture was performed at 450 nm for absorbance, using a 96 
well plate reader (Robonick). Measurements of exosome numbers were interpolated based on 
an exosome protein standard curve previously prepared. 
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3.4 WST-assay 
Proliferation was measured by WST-8 assay (Alexis Bioch.) according to the manufacturer’s 
instructions. For each condition, 1000 cells/well in triplicate for 3 time points were plated in 96 
multiwell plates. After 2 hours of incubation with WST-8 reagent, absorbance was read at 
450nm on a 96-well plate reader (Robonick). 
 
3.5 PCR analyses 
RNA from EDCs and CSps was extracted with column-based kits (Qiagen) and quantified by 
QUANTUS fluorometer (Promega). Reverse transcription was performed on 250 ng starting 
RNA (Qiagen) in a 20 µL reaction, and 1 µL of cDNA product was then subjected to realtime 
PCR with Sybr Green Supermix in a MiniOpticon instrument equipped with CFX software 
(Biorad) for 40 thermal cycles (95 °C for 10 s, 56/58 °C for 10 s, 72 °C for 30 s; see Table 2 for 
primers sequence and annealing temperatures). All primers sets were previously tested for 
optimal efficiency and all reactions were analysed by melting curves at the end to confirm 
specificity. Each reaction was performed in triplicate on at least 3 biological replicates. The 
ΔΔCt method was used for relative quantification using GAPDH as the housekeeping gene, and 
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the expression levels of EDCs and CSps in NORM media culture conditions as the reference to 
normalize the data. 
 
3.6 Immunostaining and confocal analyses 
EDCs and CSps were fixed for 10 minutes with 4% paraformaldehyde at 4°C. For 
immunofluorescence, cells were permeabilized with 0,1% Triton X-100 (Sigma) in PBS with 
1% BSA. Nonspecific antibody binding sites were blocked with 10% goat serum (Sigma-
Aldrich) before overnight incubation at 4°C with primary antibodies: Ki67 (Rabbit, AB833-500 
Abcam) and Fibronectin (Rabbit, AB2413-500 Abcam). After thorough washing, slides were 
incubated for 2 hours at room temperature with the appropriate secondary antibodies (Goat Anti-
Rabbit IgG, Alexa Fluor 568 Invitrogen) and Topro3 nuclear dye (Invitrogen). Slides were 
mounted in Vectashield medium (Vector Laboratories) and confocal fluorescence imaging was 
performed on an inverted microscope (Olympus) equipped with a spectral confocal microscopy 
system (Olympus Fluoview 1000), using a PlanApo 60x/1,42 NA immersion lens. 
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3.7 Statistical method 
Data are presented as mean value ± standard error of the mean. Two-sided Student’s t-test was 
used to evaluate the statistical significance between any two datasets. Significance threshold 
was set at P<0,05. All experiments were performed on at least three cell lines from different 
donors. 
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Table 2. Primers sequence and annealing temperatures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Target Sequence (5’-3’) T annealing 
GAPDH rv 
GAPDH fw 
GCCCAATACGACCAAATCC 
ACAGTCAGCCGCATCTTC 
58° 
GATA-4 rv 
GATA-4 fw 
AACGACGGCAACAACGATAAT 
GTTTTTTCCCCTTTGATTTTTGATC 
58° 
SMA rv 
SMA fw 
ATGAAGATCCTGACTGAGCG 
GCAGTGGCCATCTCATTTTC 
58° 
KDR rv 
KDR fw 
CGGTAGAAGCACTTGTAGGC 
AAAGGGTGGAGGTGACTGAG 
58° 
TnI rv 
TnI fw 
AGGGTGGGCCGCTTAAACT 
GGACAAGGTGGATGAAGAGA 
58° 
C-KIT rv 
C-KIT fw 
GGGATTTTCTCTGCGTTCTG 
GATGGATGGATGGTGGAGAC 
57° 
THY-1 rv 
THY-1 fw 
CGTTAGGCTGGTCACCTTCT 
CAGCGGAAGACCCCAGT 
58° 
VIM rv 
VIM fw 
GGTCATCGTGATGCTGAGAA 
ACCCACTCAAAAAGGACACTTC 
56° 
HSP90 rv 
HSP90 fw 
CAATGACATCAACTGGGCAA 
CTGTGCCGTTGGTCCTGT 
58° 
CX43 rv 
CX43 fw 
GAGTTTGCCTAAGGCGCTC 
AGGAGTTCAATCACTTGGCG 
56° 
Ki-67 rv 
Ki-67 fw 
TGACTTCCTTCCATTCTGAAGAC 
TGGGTCTGTTATTGATGAGC 
60° 
ITGA1 rv 
ITGA1 fw 
CCAAACATGTCTTCCACCG 
CTGCTGCTGGCTCCTCAC 
60° 
LAMB1 rv 
LAMB1 fw 
CAACGCAGACACACTGGC 
GAACTCTTCTGGGGAGACCC 
60° 
TLN1 rv 
TLN1 fw 
ACTGTGTGGGCTCCACTAGC 
AAGGCACTTTGTGGCTTCAC 
59° 
PXN rv 
PXN fw 
TGTGGGAGGTGGTAGACTCC 
AGCTAGCGCGACCCTGA 
59° 
COL1A1 rv 
COL1A1 fw 
CACACGTCTCGGTCATGGTA 
AAGAGGAAGGCCAAGTCGAG 
60° 
COL1A2 rv 
COL1A2 fw 
CAGGTCCTTGGAAACCTTGA 
TGCTGCTCAGTATGATGGAAA 
60° 
COL3A1 rv 
COL3A1 fw 
CATGCCCTACTGGTCCTCAG 
ATAGCCTGCGAGTCCTCCTA 
60° 
FN rv 
FN fw 
CACTCATCTCCAACGGCATAATG 
AAGACCAGCAGAGGCATAAGG 
60° 
VCL rv 
VCL fw 
AACTCTTCATCCTTTTCCTCTGG 
ACCTTGAACAACTCCGACTAAC 
60° 
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4. RESULTS 
 
4.1 FBS-derived exosomes affect EDCs culture 
In order to analyse the effects of bovine exosomes on the CSps isolation protocol, human heart 
biopsies were cultured in three different conditions, using IMDM NORM, DEPL or UCF. After 
20 days of culture (figure 2A-C) a significant reduction of EDCs yield (containing CSp-forming 
cells) in UCF media and a complete absence of cells from the explant in DEPL media were 
observed (figure 2G). As no EDCs outgrowth was obtained in the DEPL media (figure 2B), 
explants were cultured firstly in IMDM NORM and then in the three different conditions. Once 
explant-outgrowing cells reached 80% confluence, EDCs were collected and cultured 10,000 
cells/well per conditions in a Fibronectin-coated 6-multiwell plate to analyse proliferation. 
Interestingly, after 10 days, cells number indicative of cell proliferation displayed the same trend 
as explant outgrowth (figure 2D-F). In fact, the DEPL and the UCF media had a significant 
reduction of cell number compared to the NORM media (figure 2H). These data showed that 
DEPL and UCF media affected cell proliferation. In order to verify if the reduction of 
proliferation rate was directly dependent on bovine exosomes, a WST assay was performed with 
 33 
 
different bovine exosome concentrations added to the DEPL media, which has been selected for 
the lower proliferation rate shown by the cells cultured in the medium supplemented with it. 
Bovine exosomes were obtained from the ultracentrifugated FBS and were quantified with an 
ELISA assay against the CD63 exosome-specific membrane protein (figure 3A). The isolated 
exosomes were added to the DEPL media at concentrations corresponding either to 1-fold (1x) 
or 5-fold (5x) that of the normal exosome amount present in the NORM medium. This test 
allowed to determinate not only whether the exosomes had a direct effect on cell proliferation, 
but also if this effect was dose dependent. A 4 days assay was performed starting with 1000 
cells/condition using the NORM and the DEPL media as positive and negative control, 
respectively, plus the 1x and 5x media. The WST results demonstrated that the addition of 
bovine exosomes to the DEPL media rescued cell proliferation and that this effect was dose 
dependent (figure 3B-F). As expected from the ELISA quantification data, the 1x and the 
NORM media presented a similar curve trend (figure 3B). The immunofluorescence analyses 
for the proliferation marker Ki-67 confirmed the previous results. In fact, in the NORM media 
there was a higher number of Ki-67+ cells with a brighter nuclear localization than the other two 
conditions (figure 4).  The morphological analyses did not identify remarkable differences in 
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the shape of the EDCs, cultured in the three different media (figure 2D-F). Next the gene 
expression profile was analysed for markers involved in cell proliferation and migration, such 
as Ki-67, Talin-1 (TLN-1), Paxillin (PXL) and Vinculin (VCL), for the mesenchymal related 
gene THY-1 and for a heat-shock protein gene (HSP90) (figure 5). In DEPL and UCF IMDM, 
Ki-67 expression was significantly lower than in NORM media, confirming the above-
mentioned immunofluorescence data. Furthermore, THY-1 presented a significantly lower 
expression level compared to the NORM IMDM. In the DEPL IMDM, TLN-1, PXL and VLC 
were down-regulated, consistently with the reduced proliferative rate and defective explant 
outgrowth. Nevertheless, even if the TLN-1 and VLC were also down-regulated in UCF media, 
PXL resulted over-expressed, meaning that several mechanisms could be involved in cell 
spreading processes. Finally, the down-regulation of HSP90 suggested that bovine exosome-
depleted media did not increase cell stress. 
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Figure 2 Representative images of heart biopsies explant grown in different media after 30 days of culture [ IMDM NORM 
(A), IMDM DEPL (B), IMDM UCF (C) ] and their normalized EDCs yield (G) based on the average numbers of collected 
cells from each condition (n=3). Representative images of EDCs grown in different media [ IMDM NORM (D), IMDM 
DEPL (E), IMDM UCF (F) ] after 10 days of culture, starting from 10000 cells/condition, and their normalized proliferation 
rate (H) based on the average final cell numbers from each condition (n=3).  
* P<0,05 vs IMDM NORM, # P<0,05 vs IMDM DEPL. Scale bar = 100 m. 
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Figure 3 A) Quantification of exosomes concentration (number/mL) in each serum obtained with an ELISA assay against 
exosome membrane protein CD63. B) Representative WST assay of EDCs growth for 4 days in presence of different 
concentrations of bovine exosomes in the media.  C-F) Representative images of EDCs grown at different bovine exosomes 
concentration:  IMDM DEPL (C), IMDM DEPL with 1x Exosomes (D), IMDM DEPL with 5x Exosomes (E), IMDM NORM 
(F). Scale bar = 100m. 
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Figure 4 Representative confocal microscope images of immunofluorescence against Ki-67 in EDCs in different media: 
IMDM NORM (A), IMDM DEPL (B) and IMDM UCF (C).  Scale bar = 100m. 
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Figure 5 Relative gene expression levels of EDCs cultured in DEPL and UCF, normalized versus IMDM NORM (n=3).  
* P<0,05 vs IMDM NORM, # P<0,05 vs IMDM DEPL. 
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4.2 FBS-derived exosomes modulate CSps formation 
Next, the exosomes effects on the three-dimensional cell culture of CSps were analysed. EDCs, 
previously grown in IMDM NORM, were cultured in the three different CSM media on Poly-
D-Lysine coating to form CSps. After 5 days of culture, the collected CSps were counted and 
their diameter was measured (figure 6A-C). There were no differences between the DEPL and 
UCF CSM in terms of CSps yield and size (figure 6D,E). Compared to the NORM CSM, in 
DEPL and UCF media the number of CSps was significantly higher (1,63±0,29 fold), while on 
the contrary, the diameter was significantly smaller (61,0±1,5 µm vs 80±6 µm) (figure 6D,E). 
To verify whether there was a correlation between the reduced CSps dimension and the number 
of cells of each CSp, after 5 days, 1000 CSps from each condition were dissociated and cell 
number counted. As expected, in UCF media, the number of cells/CSp was lower than the 
NORM CSM (48,0±6,4 cells/CSp vs 87,0±12,7) (figure 6F). Interestingly, despite similar 
dimensions, in the DEPL media the number of cells per CSp was significantly higher compared 
to the UCF (81,0±2,1 cells/CSp vs 48,0±6,4) (figure 6F), and comparable to the NORM 
condition (81,0±2,1 cells/CSp vs 87,0±12,7) (figure 6F). These results suggested that the bovine 
exosome depletion influences CSps formation, in terms of yield, as well as cell size and 
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proliferation. To verify if the bovine exosome depletion was able to affect the gene expression 
profile of CSps, a real time PCR analysis for a representative CSp-gene panel was performed 57. 
Due to the heterogeneous niche-like nature of the CSps 18, 54, 58 we considered genes related to 
stemness (C-KIT), cardiac progenitors (GATA4), cardiac lineage (TnI, MHC, Cx43), vascular 
lineage (SMA, KDR), mesenchymal lineage (THY-1, VIM) and proliferation (Ki-67). Results 
(figure 7) suggested that the absence of bovine exosomes in the media, regardless of the 
depletion method, is associated to a significant down-regulation of the analysed genes, except 
for those vascular and mesenchymal. The Ki-67 expression level is also in agreement with the 
previous results, concerning the proliferation of CSp cells. Furthermore, considering the 
different CSp size and the average number of cells per CSp obtained in the three different media, 
some ECM related genes expression, such as Intergrin alpha 1 (ITGA1), Laminin beta 1 
(LAMB1), Collagen type I (COL1A1, COL1A2), Collagen type 3 (COL3A1) and Fibronectin 
(FN) was analysed (figure 8). Interestingly, we found that in the DEPL CSM, in which CSps 
were smaller than the NORM media, but with a similar number of cells per CSp, the ECM gene 
expressions were down-regulated. On the contrary, in the UCF, where CSps were smaller and 
the number of cells per CSp was lower, the expression of ECM genes was up-regulated. 
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According also to the FN patterns shown by confocal analyses on CSps (figure 9), these results 
suggested that the absence of bovine exosomes could affect the production of extracellular 
matrix from the cells. 
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Figure 6 Representative cell culture images of CSps after 5 days of culture in three different media: CSM NORM (A), CSM 
DEPL (B), CMS UCF (C). Average CSp numbers (D) and diameters (E) of CSps collected from each condition (n=3). F) 
Average of the numbers of cell obtained from dissociated CSps from each condition (n=3). Scale bar = 100 m. 
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Figure 7 Relative gene expression levels of CSps cultured in DEPL and UCF, versus IMDM NORM (n=3). 
 * P<0,05 vs IMDM NORM, # P<0,05 vs IMDM DEPL. 
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Figure 8 Relative ECM gene expression levels in CSps cultured in DEPL and UCF, versus IMDM NORM (n=3). 
 * P<0,05 vs IMDM NORM, # P<0,05 vs IMDM DEPL. 
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Figure 9 Representative confocal images of fibronectin stainings (red fluorescence) of CSps in different media: CSM NORM 
(A), CSM DEPL (B) and CSM (C). Scale bar = 20m. FN= fibronectin. 
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5. DISCUSSION 
 
Exosomes are present in most mammalian body fluids, such as plasma, urine and saliva, which 
means that standard culture supplement FBS contains abundant exosomal vesicles. Bovine 
serum is commonly used for in vitro cell cultures to provide hormones, growth factors and other 
proteins able to support cell survival and proliferation. Besides, bovine exosomes represent 
another serum active biological component that takes part in the FBS trophic stimuli. Two recent 
studies 39, 40 have underlined that the effects of FBS exosomes content on cell cultures are 
important factors to be considered. In fact, they demonstrated, using human tumoral cell lines, 
that depletion of bovine exosomes in the media decreased cell proliferation rate. Here, we 
analysed for the first time the effects of serum exosome-depleted media on the isolation 
procedure of primary human CPCs from explant-derived cells to three-dimensional spheroids 
(CSps). We have already demonstrated that EDCs and CSps culture yield and phenotype are 
significantly affected by different serum supplements 51. We have selected two different 
exosome-depleted FBSs: one obtained through ultracentrifugation of our commonly used FBS 
and the other one commercially available. This latter (Exo-FBS™ from System-Bio) is obtained 
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with a patented method different from ultracentrifugation, involving precipitation with a specific 
polymer able to bind exosomes. EDCs are the first cell population obtained by explant culture 
of heart tissue, as they include CSp-forming cells. They have been shown, though, to exert some 
beneficial effects with possible therapeutic potential 59. Exosome-depleted media exerted a 
negative effect on EDCs outgrowth and proliferation. We demonstrated that in DEPL and UCF 
IMDM, after 10 days of culture, cell number was significantly lower than in the NORM media, 
consistently with decreased expression of the proliferation marker Ki-67 (figure 2, figure 5). 
Furthermore, addiction to the DEPL media of different concentrations of bovine exosomes, 
isolated from commonly used FBS by ultracentrifugation, was able to restore the proliferative 
rate in a concentration-dependent manner (figure 3). Overall, these results highlight a direct role 
of FBS exosomes in cell culture proliferation. Based on the literature and on the evidence that, 
in our experimental conditions, there was a reduction of EDCs proliferation as well as spreading, 
the expression of integrin-related genes was investigated. TLN-1 and VCL are two key structural 
proteins of integrin adhesion complexes that regulate the affinity of integrins for ECM ligands, 
and are required by the actin cytoskeleton to catalyse focal adhesion-dependent pathways 60, 61. 
Talin, in particular, is the first component to be recruited to integrin/fibronectin adhesion sites 
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for the linkage with the cytoskeleton 62, suggesting a scaffolding function to bind adhesion 
complex adaptors and enzymes 63. Wang et al. attested, in fact, that talin-deficient cells, 
regardless of a normal actin cytoskeleton, showed defects in adhesion, spreading and 
proliferation due to the lack in the recruitment of vinculin, paxillin, focal adhesion kinase (FAK) 
and integrin-linked kinase 64. Consistently, we observed that talin expression was associated to 
a reduced proliferation rate. In fact, in the DEPL media, that presented the lowest proliferation 
rate, TLN, PXL and VCL expressions were reduced versus the other two conditions (figure 5).  
On the contrary, in the UCF IMDM, talin and vinculin expression levels were slightly lower 
than the NORM condition, suggesting that this down-regulation could partially impair cell 
proliferation, but not at the same level as in the DEPL media (figure 5). It was not surprising to 
have different results between DEPL and UCF IMDM; it has been already demonstrated, in fact, 
that the bovine exosomes depletion protocol from FBS could affect its biological outcome on 
cell cultures 39, 40. As mentioned above, EDCs contain CSp-forming cells. Our group was the 
first to describe the culture method to obtain spontaneous scaffold-free spheroids, called CSps, 
containing human resident adult CPCs 55. CSps mimic in vitro many aspects of a niche 
microenvironment. In fact, their architecture consists of a central core of undifferentiated cardiac 
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stem cells and interlinked by extra-cellular matrix. Compared to CPCs from monolayer cultures, 
cells of the CSp have a lower proliferation rate, but the expression of stem cell transcription 
factors (such as Oct4 and Nkx2.5) is up-regulated, as well as other factors involved in 
maintaining a stemness state and managing re-entry into the cell cycle (Gata4 and c-kit) 58, 
displaying overall a distinctive transcriptomic profile 65. Due to their composition, resident 
CPCs grown as CSps have a strong regenerative and paracrine potential in vitro and in vivo 26, 
27, 66. CSp-derived cells (CDCs) have recently and successfully been tested in the CADUCEUS 
clinical trial 21. In the perspective of clinical scalability, it is important to analyse all the possible 
factors that could affect the culture method and, in the best case, improve them. Since CSps are 
the selective/inductive stage of the culture protocol 67, in this study we have analysed for the 
first time the effects of FBS exosomes on CSps culture. Currently it is not possible to obtain 
directly from EDCs a sufficient amount of primary CSps. In fact, it is necessary to expand CSps 
as a CDCs monolayer in order to have cell numbers suitable for the in vivo applications or to 
obtain a higher number of secondary CSps 54, 68. Here we demonstrated that in presence of a low 
amount of FBS exosomes, there is a significant increase of CSps number together with a 
significant decrease of spheroids diameter (figure 6). Based on these evidences, we could 
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hypothesize that the use of an exosome-depleted serum, could be an optimization for the in vitro 
culture conditions. We also investigated if exosome depletion affected the gene expression 
pattern of CSps. RTqPCR analyses were directed against a list of genes that are normally 
expressed in CSps due to their heterogeneous structure, including genes related to stemness, 
cardiac and vascular lineages (figure 7). In terms of cardiac and stemness genes, we observed 
overall a significant down-regulation in exosome-depleted conditions. These results evidenced 
an important influence of bovine exosomes on cardiac commitment of CSps, besides 
maintenance of their stem potential. Based on the results concerning proliferation and Ki-67 
expression, CSps from each condition were dissociated and the ratio cells number/CSp was 
analysed. Interestingly, despite similar size, the cell number per CSp in the UCF CSM was 
significantly lower than the DEPL media (figure 6F). Furthermore, this latter presented a cell 
number/CSp comparable to the NORM CSM that together with higher CSp yield suggested 
higher cell numbers overall, supporting the results on proliferation. We could hypothesize, 
concerning the DEPL CSM results, a sort of “paradox effect” of bovine exosomes depletion that 
stimulates proliferation in the 3D structure, but inhibits the same in the monolayer. DEPL and 
UCF media CSps presented comparable size but different number of cells per CSp. To 
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understand at least in part these differences, we analysed the expression of ECM-related genes 
that characterize CSps 58 (figure 8). In the DEPL CSM, gene expression levels were overall 
down-regulated. On the contrary, in the UCF condition, except for ITGA-1 and FN, all the ECM 
related markers were significantly up-regulated. These results were confirmed also by the 
confocal analyses of fibronectin expression on CSps from each condition (figure 9). We could 
hypothesize that FBS exosomes were able to modulate ECM production, but it is still unclear, 
and need a deeper analyses, if this effect is due directly to exosomes depletion or not. It has been 
demonstrated that various depletion methods are able to differentially affect cell cultures in vitro 
39. Here we demonstrated that by using two exosome-depleted sera, produced with different 
methods, we obtained distinctive results in terms of proliferation and gene expression profiles. 
For example, concerning the mesenchymal component normally present in CPCs culture, even 
if we observed in both EDCs and CSps a significant down-regulation of the related gene THY-
1 (figure 5 and figure 7), the amount of such effect was different between the two exosome-
depleted FBSs. These results confirm that the depletion method can affect exosome quantity, as 
well as quality, and possibly their content, exerting in the end different stimuli on the same cell 
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type 69, 70. Further analyses, that are not the aims of this work, will be necessary to verify this 
hypothesis.  
 
6. CONCLUSION 
 
In conclusion, we verified that FBS exosome-depletion reduced EDCs proliferation, and the 
expression of adhesion molecules, and that adding exosomes to depleted media it is possible to 
restore proliferation rate in a dose-dependent manner. In 3D CPCs culture, exosome-depleted 
FBSs affected CSps yield, dimension and ECM production. In addition, we observed that CSps 
displayed a more undifferentiated phenotype. Future efforts may evaluate their effects in terms 
of functional benefits to understand if the selective and/or timely use of an exosome-depleted 
FBS in the media could be an improvement or adjuvant of the culture method for a clinical 
scalability. 
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